AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 66 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $929,681 | +124.0% | 62,186 | +23.3% | 0.00% | – |
| Q3 2022 | $415,000 | +21.3% | 50,441 | -3.3% | 0.00% | – |
| Q2 2022 | $342,000 | +14.0% | 52,146 | -2.6% | 0.00% | – |
| Q1 2022 | $300,000 | +12.4% | 53,547 | -6.0% | 0.00% | – |
| Q4 2021 | $267,000 | -27.2% | 56,944 | -3.8% | 0.00% | – |
| Q3 2021 | $367,000 | -0.5% | 59,181 | +5.7% | 0.00% | – |
| Q2 2021 | $369,000 | -78.0% | 55,993 | -75.5% | 0.00% | – |
| Q1 2021 | $1,675,000 | +19.6% | 228,786 | -5.8% | 0.00% | – |
| Q4 2020 | $1,401,000 | +3.3% | 242,839 | +6.3% | 0.00% | – |
| Q3 2020 | $1,356,000 | +63.4% | 228,369 | +41.7% | 0.00% | – |
| Q2 2020 | $830,000 | +822.2% | 161,217 | +548.3% | 0.00% | – |
| Q1 2020 | $90,000 | – | 24,869 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PATHWAY CAPITAL MANAGEMENT, LP | 245,606 | $3,671,810 | 6.55% |
| AIGH Capital Management LLC | 695,358 | $10,395,602 | 3.42% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 638,360 | $9,544 | 2.08% |
| Kellner Capital, LLC | 100,016 | $1,495 | 1.74% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,464,807 | $21,898,865 | 1.70% |
| Worth Venture Partners, LLC | 170,925 | $2,555,329 | 1.51% |
| Birchview Capital, LP | 100,000 | $1,495 | 1.06% |
| BCK CAPITAL MANAGEMENT LP | 68,000 | $1,016,600 | 1.05% |
| WATER ISLAND CAPITAL LLC | 698,915 | $10,449 | 0.89% |
| EHP Funds Inc. | 292,043 | $4,366 | 0.82% |